Literature DB >> 31372696

Dopamine D1 receptor antagonist reduces stimulant-induced conditioned place preferences and dopamine receptor supersensitivity.

Sun Mi Gu1, Hye Jin Cha2, So Woon Seo1, Jin Tae Hong3, Jaesuk Yun4.   

Abstract

Repeated administration of stimulants induces conditioned place preference (CPP). Dopamine receptor supersensitivity is developed in stimulant-induced CPP animals; however, dopamine receptor subtypes associated with the development of supersensitivity in CPP animals are largely unknown. The present preclinical study aimed to examine whether dopamine D1 or D2 receptor antagonists exert inhibitory effects on stimulant-induced psychological behaviors. Additionally, the authors aimed to elucidate the role of dopamine receptor supersensitivity on the development of reward-related behavior. Sprague Dawley rats subjected to methamphetamine- and cocaine-induced CPP tests were treated with dopamine D1 (SCH23390) or D2 (sulpiride) receptor antagonists. Following the CPP experiment, rats were challenged with apomorphine (dopamine receptor agonist), and locomotor activity was measured. Methamphetamine- and cocaine-induced CPP was reduced with the administration of SCH23390, but not sulpiride. In addition, the apomorphine challenge evoked an increase in locomotor activity in stimulant-pre-treated rats, reflecting dopamine receptor supersensitivity. SCH23390 pre-treatment inhibited the development of dopamine receptor supersensitivity, while sulpiride demonstrated no inhibitory effects. These results suggest that the dopamine D1 receptor antagonist SCH23390 inhibits the development of dopamine receptor supersensitivity which is associated with the development of CPP.

Entities:  

Keywords:  Addiction; Cocaine; Dopamine receptor subtype; Dopamine receptor supersensitivity; Methamphetamine

Mesh:

Substances:

Year:  2019        PMID: 31372696     DOI: 10.1007/s00210-019-01694-3

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  36 in total

1.  Inhibitory effects of ginseng total saponin on nicotine-induced hyperactivity, reverse tolerance and dopamine receptor supersensitivity.

Authors:  H S Kim; K S Kim
Journal:  Behav Brain Res       Date:  1999-08       Impact factor: 3.332

2.  Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice.

Authors:  H S Kim; C G Jang; W K Park
Journal:  Pharmacol Biochem Behav       Date:  1996-09       Impact factor: 3.533

Review 3.  The neural basis of drug craving: an incentive-sensitization theory of addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Brain Res Brain Res Rev       Date:  1993 Sep-Dec

4.  Blockade by ginseng total saponin of the development of cocaine induced reverse tolerance and dopamine receptor supersensitivity in mice.

Authors:  H S Kim; J G Kang; Y H Seong; K Y Nam; K W Oh
Journal:  Pharmacol Biochem Behav       Date:  1995-01       Impact factor: 3.533

5.  Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat.

Authors:  S B Caine; G F Koob
Journal:  J Pharmacol Exp Ther       Date:  1994-07       Impact factor: 4.030

6.  Role of dopamine D1- and D2-like receptor mechanisms in drug-seeking following methamphetamine self-administration in rats.

Authors:  Caleb Carati; Susan Schenk
Journal:  Pharmacol Biochem Behav       Date:  2011-02-17       Impact factor: 3.533

7.  Effects of ginseng total saponin on morphine-induced hyperactivity and conditioned place preference in mice.

Authors:  H S Kim; C G Jang; K W Oh; S Oh; H M Rheu; G S Rhee; Y H Seong; W K Park
Journal:  J Ethnopharmacol       Date:  1998-02       Impact factor: 4.360

8.  Cocaine self-administration produces a persistent increase in dopamine D2 High receptors.

Authors:  Lisa A Briand; Shelly B Flagel; Philip Seeman; Terry E Robinson
Journal:  Eur Neuropsychopharmacol       Date:  2008-03-04       Impact factor: 4.600

9.  Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopamine-receptor supersensitivity in mice.

Authors:  H S Kim; W K Park; C G Jang; S Oh
Journal:  Brain Res Bull       Date:  1996       Impact factor: 4.077

10.  Initial d2 dopamine receptor sensitivity predicts cocaine sensitivity and reward in rats.

Authors:  Kathryn E Merritt; Ryan K Bachtell
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

View more
  7 in total

1.  Knockdown of Piccolo in the Nucleus Accumbens Suppresses Methamphetamine-Induced Hyperlocomotion and Conditioned Place Preference in Mice.

Authors:  Yuka Kusui; Naotaka Izuo; Kyosuke Uno; Bin Ge; Shin-Ichi Muramatsu; Atsumi Nitta
Journal:  Neurochem Res       Date:  2022-07-29       Impact factor: 4.414

Review 2.  Identification of the Risk Genes Associated With Vulnerability to Addiction: Major Findings From Transgenic Animals.

Authors:  Chloe J Jordan; Zheng-Xiong Xi
Journal:  Front Neurosci       Date:  2022-01-12       Impact factor: 4.677

3.  Distinct Role of Dopamine in the PFC and NAc During Exposure to Cocaine-Associated Cues.

Authors:  Yukie Kawahara; Yoshinori N Ohnishi; Yoko H Ohnishi; Hiroshi Kawahara; Akinori Nishi
Journal:  Int J Neuropsychopharmacol       Date:  2021-12-08       Impact factor: 5.176

4.  Caveolin-1 Expression in the Dorsal Striatum Drives Methamphetamine Addiction-Like Behavior.

Authors:  Yosef Avchalumov; Alison D Kreisler; Wulfran Trenet; Mahasweta Nayak; Brian P Head; Juan C Piña-Crespo; Chitra D Mandyam
Journal:  Int J Mol Sci       Date:  2021-07-30       Impact factor: 6.208

5.  SCH23390 Reduces Methamphetamine Self-Administration and Prevents Methamphetamine-Induced Striatal LTD.

Authors:  Yosef Avchalumov; Wulfran Trenet; Juan Piña-Crespo; Chitra Mandyam
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

6.  Isoliquiritigenin, a potent human monoamine oxidase inhibitor, modulates dopamine D1, D3, and vasopressin V1A receptors.

Authors:  Ritu Prajapati; Su Hui Seong; Se Eun Park; Pradeep Paudel; Hyun Ah Jung; Jae Sue Choi
Journal:  Sci Rep       Date:  2021-12-07       Impact factor: 4.379

Review 7.  Current and Emerging Treatments for Methamphetamine Use Disorder.

Authors:  Anna Moszczynska
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.